Lingjian Zhang

774 total citations
37 papers, 565 citations indexed

About

Lingjian Zhang is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Lingjian Zhang has authored 37 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 17 papers in Hepatology and 8 papers in Molecular Biology. Recurrent topics in Lingjian Zhang's work include Liver Disease Diagnosis and Treatment (15 papers), Liver Disease and Transplantation (10 papers) and Liver physiology and pathology (5 papers). Lingjian Zhang is often cited by papers focused on Liver Disease Diagnosis and Treatment (15 papers), Liver Disease and Transplantation (10 papers) and Liver physiology and pathology (5 papers). Lingjian Zhang collaborates with scholars based in China and United States. Lingjian Zhang's co-authors include Lanjuan Li, Yalei Zhao, Lingfei Zhao, Lanjuan Li, Qiongling Bao, Chenxia Hu, Zhongyang Xie, Xiaoxi Ouyang, Lanlan Xiao and Fen Zhang and has published in prestigious journals such as Advanced Functional Materials, Scientific Reports and Chemical Engineering Journal.

In The Last Decade

Lingjian Zhang

35 papers receiving 562 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingjian Zhang China 14 199 161 151 85 76 37 565
Kan Chen China 18 226 1.1× 96 0.6× 166 1.1× 80 0.9× 51 0.7× 36 912
Hanwei Li China 14 209 1.1× 162 1.0× 145 1.0× 133 1.6× 129 1.7× 27 604
Lichao Yao China 12 160 0.8× 120 0.7× 85 0.6× 120 1.4× 76 1.0× 30 587
Guangli Ren China 12 214 1.1× 69 0.4× 124 0.8× 65 0.8× 90 1.2× 20 543
Jinglin Wang China 12 206 1.0× 65 0.4× 87 0.6× 103 1.2× 101 1.3× 25 533
Shihao Xu China 16 282 1.4× 105 0.7× 47 0.3× 143 1.7× 113 1.5× 51 725
Kwan Man Hong Kong 9 204 1.0× 149 0.9× 72 0.5× 38 0.4× 32 0.4× 14 435
Minyue Zhang China 10 190 1.0× 93 0.6× 72 0.5× 47 0.6× 33 0.4× 25 526
Meng-Lan Wang China 15 114 0.6× 333 2.1× 363 2.4× 152 1.8× 62 0.8× 42 720
Yunyun Luo Denmark 10 186 0.9× 82 0.5× 37 0.2× 111 1.3× 58 0.8× 23 645

Countries citing papers authored by Lingjian Zhang

Since Specialization
Citations

This map shows the geographic impact of Lingjian Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingjian Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingjian Zhang more than expected).

Fields of papers citing papers by Lingjian Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingjian Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingjian Zhang. The network helps show where Lingjian Zhang may publish in the future.

Co-authorship network of co-authors of Lingjian Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Lingjian Zhang. A scholar is included among the top collaborators of Lingjian Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingjian Zhang. Lingjian Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhang, Lingjian, Fangfang Zhang, Zhiyuan Ma, & Jie Jin. (2024). Hepatitis B virus infection, infertility, and assisted reproduction. Journal of Zhejiang University SCIENCE B. 25(8). 672–685. 4 indexed citations
3.
Zhang, Lingjian, Lingzhou Zhao, Yu‐Sheng Chen, et al.. (2024). A narrow-bandgap RuI3 nanoplatform to synergize radiotherapy, photothermal therapy, and thermoelectric dynamic therapy for tumor eradication. Acta Biomaterialia. 182. 188–198. 4 indexed citations
4.
Zhang, Lingjian, Yawen Liu, Min Tang, et al.. (2024). Sulphated Fucooligosaccharide from Sargassum Horneri: Structural Analysis and Anti-Alzheimer Activity. Neurochemical Research. 49(6). 1592–1602. 2 indexed citations
5.
Zhu, Huihui, Qiuhong Liu, Lingjian Zhang, et al.. (2024). CCT3/ACTN4/TFRC axis protects hepatocellular carcinoma cells from ferroptosis by inhibiting iron endocytosis. Journal of Experimental & Clinical Cancer Research. 43(1). 245–245. 11 indexed citations
6.
Zhang, Lingjian, Yalei Zhao, Zhongyang Xie, et al.. (2022). 1,5-Anhydroglucitol Predicts Mortality in Patients with HBV-Related Acute-on-chronic Liver Failure. Journal of Clinical and Translational Hepatology. 10(4). 651–659. 2 indexed citations
7.
Hu, Qingqing, et al.. (2022). SGOL2 is a novel prognostic marker and fosters disease progression via a MAD2-mediated pathway in hepatocellular carcinoma. Biomarker Research. 10(1). 82–82. 7 indexed citations
8.
Wu, Xiaoxin, Xiaoyun Ma, Lingjian Zhang, et al.. (2022). Immune Enhancement by the Tetra-Peptide Hydrogel as a Promising Adjuvant for an H7N9 Vaccine against Highly Pathogenic H7N9 Virus. Vaccines. 10(1). 130–130. 11 indexed citations
9.
Yang, Ya, Yanfei Chen, Yalei Zhao, et al.. (2022). Human menstrual blood-derived stem cell transplantation suppresses liver injury in DDC-induced chronic cholestasis. Stem Cell Research & Therapy. 13(1). 57–57. 10 indexed citations
10.
Hu, Qingqing, et al.. (2021). Targeting Hedgehog signalling in CD133-positive hepatocellular carcinoma: improving Lenvatinib therapeutic efficiency. Medical Oncology. 38(4). 41–41. 17 indexed citations
11.
Ji, Feiyang, Zeyu Sun, Zhengyi Jiang, et al.. (2021). Integrative proteomics reveals the role of E3 ubiquitin ligase SYVN1 in hepatocellular carcinoma metastasis. Cancer Communications. 41(10). 1007–1023. 32 indexed citations
12.
Yang, Ya, Yalei Zhao, Lingjian Zhang, Fen Zhang, & Lanjuan Li. (2021). The Application of Mesenchymal Stem Cells in the Treatment of Liver Diseases: Mechanism, Efficacy, and Safety Issues. Frontiers in Medicine. 8. 655268–655268. 32 indexed citations
13.
Ma, Shanshan, Zhongyang Xie, Lingjian Zhang, et al.. (2021). Identification of a Potential miRNA–mRNA Regulatory Network Associated With the Prognosis of HBV-ACLF. Frontiers in Molecular Biosciences. 8. 657631–657631. 9 indexed citations
14.
Zhao, Yalei, et al.. (2020). COVID-19 in Elderly Adults: Clinical Features, Molecular Mechanisms, and Proposed Strategies. Aging and Disease. 11(6). 1481–1481. 9 indexed citations
15.
Hu, Chenxia, Lingfei Zhao, Lingjian Zhang, Qiongling Bao, & Lanjuan Li. (2020). Mesenchymal stem cell-based cell-free strategies: safe and effective treatments for liver injury. Stem Cell Research & Therapy. 11(1). 377–377. 107 indexed citations
16.
Ma, Shanshan, Zhongyang Xie, Lingjian Zhang, et al.. (2020). Characterization of an Artificial Liver Support System‐Related Vasovagal Reaction. BioMed Research International. 2020(1). 6313480–6313480.
17.
Zhao, Yalei, Lingjian Zhang, Xiaoxi Ouyang, et al.. (2019). Advanced oxidation protein products play critical roles in liver diseases. European Journal of Clinical Investigation. 49(6). e13098–e13098. 31 indexed citations
18.
Zhang, Lingjian, Yalei Zhao, Linxiao Fan, et al.. (2019). Tectorigenin protects against experimental fulminant hepatic failure by regulating the TLR4/mitogen‐activated protein kinase and TLR4/nuclear factor‐κB pathways and autophagy. Phytotherapy Research. 33(4). 1055–1064. 26 indexed citations
19.
Chen, Da‐Zhi, Feiyang Ji, Qiaomai Xu, et al.. (2018). Interaction of smoking and metabolic syndrome in increasing the recurrence risk of colorectal cancer in a Chinese male cohort: a retrospective study. Scientific Reports. 8(1). 972–972. 14 indexed citations
20.
Zhang, Lingjian, Qianfeng Liu, Hui Zhang, et al.. (2013). Two new antitumor constituents from a soil fungus Curvularia inaequalis (strain HS-FG-257). The Journal of Antibiotics. 66(5). 287–289. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kan Chen Breakdown of academic impact, for papers by Hanwei Li Breakdown of academic impact, for papers by Lichao Yao Breakdown of academic impact, for papers by Guangli Ren Breakdown of academic impact, for papers by Jinglin Wang Breakdown of academic impact, for papers by Shihao Xu Breakdown of academic impact, for papers by Kwan Man Breakdown of academic impact, for papers by Minyue Zhang Breakdown of academic impact, for papers by Meng-Lan Wang Breakdown of academic impact, for papers by Yunyun Luo
Rankless by CCL
2026